| 2023 Active Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| CA23-034 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) | EXPIRED - AUG 22, 2023 |
| 2023 Active Trans-NIH Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PA23-231 PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) | ACTIVE - APR 06, 2024 |
| PA23-230 PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) | ACTIVE - APR 06, 2024 |